Literature DB >> 23902756

Secular trends in cardiovascular disease and its risk factors in Japanese: half-century data from the Hisayama Study (1961-2009).

Jun Hata1, Toshiharu Ninomiya, Yoichiro Hirakawa, Masaharu Nagata, Naoko Mukai, Seiji Gotoh, Masayo Fukuhara, Fumie Ikeda, Kentaro Shikata, Daigo Yoshida, Koji Yonemoto, Masahiro Kamouchi, Takanari Kitazono, Yutaka Kiyohara.   

Abstract

BACKGROUND: Changes in lifestyle and advances in medical technology during the past half century are likely to have affected the incidence and mortality of cardiovascular disease and the prevalence of its risk factors in Japan. METHODS AND
RESULTS: We established 5 cohorts consisting of residents aged ≥40 years in a Japanese community, in 1961 (n=1618), 1974 (n=2038), 1983 (n=2459), 1993 (n=1983), and 2002 (n=3108), and followed up each cohort for 7 years. The age-adjusted incidence of stroke decreased greatly, by 51% in men and by 43% in women, from the 1960s to the 1970s, but this decreasing trend slowed from the 1970s to the 2000s. Among the stroke subtypes, ischemic stroke in both sexes and intracerebral hemorrhage in men showed a similar pattern. Stroke mortality decreased as a result of the decline in incidence and a significant improvement in survival rate. Although the incidence of acute myocardial infarction did not change in either sex, disease mortality declined slightly in women. From the 1960s to the 2000s, blood pressure control among hypertensive individuals improved significantly and the smoking rate decreased, but the prevalence of glucose intolerance, hypercholesterolemia, and obesity increased steeply.
CONCLUSIONS: Our findings suggest that in Japanese, the decreasing trends in the incidence of ischemic stroke have recently slowed down, and there has been no clear change in the incidence of acute myocardial infarction, probably because the benefits of hypertension control and smoking cessation have been negated by increasing metabolic risk factors.

Entities:  

Keywords:  coronary disease; incidence; mortality; stroke; trends

Mesh:

Year:  2013        PMID: 23902756     DOI: 10.1161/CIRCULATIONAHA.113.002424

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  90 in total

1.  Trajectories of kidney function and associated factors among community-dwelling older Japanese: a 16-year longitudinal study.

Authors:  Sho Kaito; Yu Taniguchi; Akihiko Kitamura; Satoshi Seino; Hidenori Amano; Yuri Yokoyama; Hiroshi Fukuda; Hirohide Yokokawa; Yoshinori Fujiwara; Shoji Shinkai; Toshio Naito
Journal:  Clin Exp Nephrol       Date:  2019-12-26       Impact factor: 2.801

2.  10-year results of On-X bileaflet mechanical heart valve in the aortic position: low target INR regimen in Japanese.

Authors:  Hideki Teshima; Masahiko Ikebuchi; Yosuke Miyamoto; Ryuta Tai; Toshikazu Sano; Yusuke Kinugasa; Hiroyuki Irie
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-04-19

3.  Continuous decline in mortality from coronary heart disease in Japan despite a continuous and marked rise in total cholesterol: Japanese experience after the Seven Countries Study.

Authors:  Akira Sekikawa; Yoshihiro Miyamoto; Katsuyuki Miura; Kunihiro Nishimura; Bradley J Willcox; Kamal H Masaki; Beatriz Rodriguez; Russell P Tracy; Tomonori Okamura; Lewis H Kuller
Journal:  Int J Epidemiol       Date:  2015-07-16       Impact factor: 7.196

4.  Cross-sectional comparison of coronary artery calcium scores between Caucasian men in the United States and Japanese men in Japan: the multi-ethnic study of atherosclerosis and the Shiga epidemiological study of subclinical atherosclerosis.

Authors:  Akira Fujiyoshi; Katsuyuki Miura; Takayoshi Ohkubo; Takashi Kadowaki; Sayaka Kadowaki; Maryam Zaid; Takashi Hisamatsu; Akira Sekikawa; Matthew J Budoff; Kiang Liu; Hirotsugu Ueshima
Journal:  Am J Epidemiol       Date:  2014-08-13       Impact factor: 4.897

5.  Development and validation of a risk assessment tool for gastric cancer in a general Japanese population.

Authors:  Masahiro Iida; Fumie Ikeda; Jun Hata; Yoichiro Hirakawa; Tomoyuki Ohara; Naoko Mukai; Daigo Yoshida; Koji Yonemoto; Motohiro Esaki; Takanari Kitazono; Yutaka Kiyohara; Toshiharu Ninomiya
Journal:  Gastric Cancer       Date:  2017-10-17       Impact factor: 7.370

6.  White-coat and masked hypertension are associated with albuminuria in a general population: the Hisayama Study.

Authors:  Jun Hata; Masayo Fukuhara; Satoko Sakata; Hisatomi Arima; Yoichiro Hirakawa; Koji Yonemoto; Naoko Mukai; Takanari Kitazono; Yutaka Kiyohara; Toshiharu Ninomiya
Journal:  Hypertens Res       Date:  2017-09-07       Impact factor: 3.872

7.  The long-term association between physical activity and risk of dementia in the community: the Hisayama Study.

Authors:  Hiro Kishimoto; Tomoyuki Ohara; Jun Hata; Toshiharu Ninomiya; Daigo Yoshida; Naoko Mukai; Masaharu Nagata; Fumie Ikeda; Masayo Fukuhara; Shuzo Kumagai; Shigenobu Kanba; Takanari Kitazono; Yutaka Kiyohara
Journal:  Eur J Epidemiol       Date:  2016-02-08       Impact factor: 8.082

8.  Coronary Artery Calcium Progression Among the US and Japanese Men.

Authors:  Takashi Hisamatsu; Kiang Liu; Cheeling Chan; Amy E Krefman; Akira Fujiyoshi; Matthew J Budoff; Katsuyuki Miura; Donald M Lloyd-Jones; Hirotsugu Ueshima
Journal:  Circ Cardiovasc Imaging       Date:  2019-02       Impact factor: 7.792

9.  Five-Year Incidence of Myopic Maculopathy in a General Japanese Population: The Hisayama Study.

Authors:  Emi Ueda; Miho Yasuda; Kohta Fujiwara; Sawako Hashimoto; Kyoko Ohno-Matsui; Jun Hata; Tatsuro Ishibashi; Toshiharu Ninomiya; Koh-Hei Sonoda
Journal:  JAMA Ophthalmol       Date:  2020-08-01       Impact factor: 7.389

10.  Recent status of self-measured home blood pressure in the Japanese general population: a modern database on self-measured home blood pressure (MDAS).

Authors:  Kei Asayama; Yasuharu Tabara; Emi Oishi; Satoko Sakata; Takashi Hisamatsu; Kayo Godai; Mai Kabayama; Yukako Tatsumi; Jun Hata; Masahiro Kikuya; Kei Kamide; Katsuyuki Miura; Toshiharu Ninomiya; Takayoshi Ohkubo
Journal:  Hypertens Res       Date:  2020-08-05       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.